Clinical benefit of COX-2 inhibitors in the adjuvant chemotherapy of advanced non-small cell lung cancer: A systematic review and meta-analysis

Figure 1 Summary of trial identification and selection.

Figure 2 Subgroup analyses of forest plot for overall survival.

Figure 3 Subgroup analyses of forest plot for progression free survival.

Figure 4 Subgroup analyses of forest plot for 1-year survival rate.

Figure 5 Subgroup analyses of forest plot for overall response rate.

Figure 6 Subgroup analyses of forest plot for clinical benefit.

Figure 7 Subgroup analyses of forest plot for complete response.

Figure 8 Subgroup analyses of forest plot for partial response.

Figure 9 Subgroup analyses of forest plot for stable disease.